Rhonda Farnum - 28 Feb 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
28 Feb 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 18:05:02 UTC
Previous filing
24 Feb 2025
Next filing
23 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $0 +75,000 +25% $0.000000 374,038 28 Feb 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.